Periodic reinterpretation of genetic sequencing results presents a challenge for developing transparent and systematic coverage and reimbursement policies.
John E. Schneider, PhD
Advertisement
Articles by John E. Schneider, PhD
The health savings account-eligible design may decrease costs and utilization, but it also may decrease use of preventive services.
Advertisement
Latest Updated Articles
- Reimbursement for Genetic Variant Reinterpretation: Five Questions Payers Should Ask
Published: October 14th 2021 | Updated:
- Effects of Health Savings Account Eligible Plans on Utilization and Expenditures
Published: January 29th 2011 | Updated:
Advertisement
Advertisement
Trending on AJMC
1
New Legislation Aims to Address Transparency in PBMs as First Major Step in Reform
2
FDA to Restrict Ingredients Used in Mass-Marketed Compounded GLP-1s, Crack Down on Misleading Ads
3
Overcoming Mistrust in Clinical Trial Enrollment Through Community Resources: Susan Vadaparampil, PhD, MPH
4
Catchment Areas Shape Diversity and Access in Oncology Trials: Amir Fathi, MD
5